Tyson Bioresearch Inc. (“TysonBio”) is one of the world's leading medical device companies devoted to innovating, manufacturing, and sales of advanced in-vitro diagnostic medical products. To further innovate and develop different applications of advanced blood glucose monitoring systems and related technology, TysonBio decided to build its new plant in the Biomedical Park in Hsinchu, Taiwan, and held its groundbreaking ceremony today. The plant will not only adopt automatic, intelligent, energy-saving manufacturing processes, but also manufacture the next generation of in-vitro diagnostic devices and materials for single and continuous measurements based on proprietary electrochemical mechanisms on its developed electrode device platform and optical platform. By collaborating with multiple medical specialties and partners, the diagnostic system will utilize intelligent adaptive feedback and personalized big data to achieve precision medicine.
TysonBio was founded in 1999 with its headquarter located in the Zhunan Science Park, Taiwan, and sales office in Taipei, Taiwan. Its advanced blood glucose monitoring systems have received product certifications from Taiwan TFDA, US FDA, EU CE, and other countries’ authorities, and are distributed to more than 40 countries worldwide. It has also obtained multiple patents in the US, Taiwan, and China for the electrochemical platform and its algorithm for detecting wide hematocrit range. Moreover, TysonBio has received product design recognitions from the Red Dot Design Award and Good Design Award.
Upholding the philosophy of sustainable operation, TysonBio regards product quality and human talent as its most important goals. The new plant will focus on a comfortable working environment, the efficiency of usage, and the reduction of negative impact on both the human body as well as the environment. Designed with that in mind, the new plant will obtain LEED, EEWH, and WELL certifications. This project is not only expected to realize TysonBio’s core values of “caring for people” and “protecting the environment” but also to raise the competitiveness of the domestic medical device industry and foster collaborative talent for biochemistry. No doubt it will become one of the new highlights of the Biomedical Park in the foreseeable future.
-- Tyson Bio new plant 3D visual